Cromakalim
Structural formula of cromakalim
Ball-and-stick model of the cromakalim molecule
Clinical data
ATC code
  • none
Identifiers
  • (3R,4S)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)chroman-6-carbonitrile
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC16H18N2O3
Molar mass286.331 g·mol−1
3D model (JSmol)
  • O=C3N([C@H]1c2c(OC([C@@H]1O)(C)C)ccc(C#N)c2)CCC3

Cromakalim (INN) is a potassium channel-opening vasodilator. The active isomer is levcromakalim. It acts on ATP-sensitive potassium channels and so causes membrane hyperpolarization. It can be used to treat hypertension as it will relax vascular smooth muscle to lower blood pressure. Hyperpolarisation of smooth muscle cell membranes pulls their membrane potential away from the threshold, so making it more difficult to excite them and thereby cause relaxation.

Synthesis

Levcromakalim synthesis:[1][2] racemate:[3] of isomers:[4]

Reaction of 4-cyanophenol[5] (4-Hydroxybenzonitrile) with 2-hydroxy-2-methyl-3-butyne under PTC probably proceeds to initial formation of a propargyl carbocation. The course of the reaction can be envisaged by assuming that this then attacks the aromatic ring; the resulting allylic cation can then capture the adjacent phenol oxygen and thus form the observed product (3). Treatment of that product with aqueous NBS leads to the addition of the elements of hypobromous acid and formation of the bromohydrin (4) as a mixture of the trans enantiomers. This cyclizes to the epoxide 5 in the presence of sodium hydroxide (5). Ring opening of the oxirane with ammonia gives a mixture of the trans amino alcohols (6). These are probably resolved at this stage and the 3S,4R-enantiomer used in the next stage. That isomer is next acylated with 4-Chlorobutyryl chloride[6] to give the chloroamide (7). The anion from reaction of the amide with sodium hydride then displaces the chlorine on the end of the chain to form the pyrrolidine ring. There is thus obtained levcromakalim (8).

References

  1. ↑ Anon., Drugs Future 11, 175 (1986).
  2. ↑ Ashwood VA, Buckingham RE, Cassidy F, Evans JM, Faruk EA, Hamilton TC, et al. (November 1986). "Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans". Journal of Medicinal Chemistry. 29 (11): 2194–201. doi:10.1021/jm00161a011. PMID 3783581.
  3. ↑ EP 76075, Evans, John Morris; Buckingham, Robert Edwin & Willcocks, Kenneth, "Pharmaceutically active benzopyran compounds", published 1983-04-06, assigned to Beecham Group plc; J. M. Evans et al., U.S. Patent 4,446,113 (1984 to Beecham).
  4. ↑ EP 120428, Faruk, Erol, "Benzopyran isomers", published 1984-10-03, assigned to Beecham Group plc
  5. ↑ U.S. Patent 3,444,236
  6. ↑ "Synthesis of 4-Chlorobutyryl Chloride". cnki.com.cn. Archived from the original on 2022-10-14. Retrieved 2015-11-20.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.